AnalystsRobert YoungRobert Young's Stock Forecasts
AnalystsRobert Young
Analyst Ranking
Top 30%
#1523 out of 5049 analysts
Average Return
+23.72%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Robert Young's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celestica IncCLS | +223.18% | $52.67 | $170.22 | 2024-07-25 - 2025-07-25 | Strong Buy |
Celestica IncCLS | +154.20% | $20.72 | $52.67 | 2023-07-27 - 2024-07-26 | Strong Buy |
Docebo IncDCBO | +47.06% | $35.42 | $52.09 | 2023-03-09 - 2024-03-08 | Strong Buy |
Celestica IncCLS | +17.48% | $202.41 | $237.79 | 2025-07-29 - 2025-10-07 | Strong Buy |
Celestica IncCLS | +12.14% | $11.20 | $12.56 | 2022-06-06 - 2023-06-06 | Strong Buy |
Robert Young Analyst Color
Get additional color on Robert Young's coverage of popular stocks
Robert Young's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celestica IncCLS | 5 | Strong Buy | $240.00 | +0.93% | Maintains | 2 months ago |
Docebo IncDCBO | 3 | Strong Buy | $55.00 | N/A | Maintains | a year ago |
Sangoma Technologies CorpSANG | 3 | Hold | $3.25 | N/A | Downgrades | 2 years ago |
Enthusiast Gaming Holdings IncEGLXF | 1 | Strong Buy | $3.50 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.